A detailed history of Trek Financial, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Trek Financial, LLC holds 5,617 shares of NVO stock, worth $272,199. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,617
Previous 4,277 31.33%
Holding current value
$272,199
Previous $295,000 5.42%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 31, 2025

BUY
$45.38 - $71.7 $60,809 - $96,078
1,340 Added 31.33%
5,617 $311,000
Q2 2025

Aug 13, 2025

BUY
$58.08 - $81.05 $248,408 - $346,650
4,277 New
4,277 $295,000
Q4 2024

Feb 13, 2025

BUY
$85.0 - $120.04 $209,440 - $295,778
2,464 New
2,464 $211,000
Q2 2024

Aug 12, 2024

BUY
$122.71 - $146.91 $225,786 - $270,314
1,840 New
1,840 $262,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $109B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Trek Financial, LLC Portfolio

Follow Trek Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trek Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trek Financial, LLC with notifications on news.